# Franklin Templeton Digital Holdings Trust: financial statements, quarterly

EZBC · CBOE · CIK 1992870 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/ezbc.md) · [Financials](/companies/ezbc/financials.md) · [Filings](/companies/ezbc/filings.md) · [Insiders](/companies/ezbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ezbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2025 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [61.2](/filings/0001140361-25-024065.md) | [(36.3)](/filings/0001140361-25-030876.md) | [2.7](/filings/0001140361-25-041932.md) | [214](/filings/0001140361-26-005787.md) | [(71.1) d](/filings/0001140361-26-026744.md) | [128](/filings/0001140361-26-033208.md) | [28.1](/filings/0001140361-25-041932.md) | [(157)](/filings/0001140361-26-005787.md) | [(118) d](/filings/0001140361-26-026744.md) | [(46.6)](/filings/0001140361-26-033208.md) |

- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q1 FY2025 (2023-12-31) | FY2025 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001193125-24-044319.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [0.1](/filings/0001193125-24-044319.md) | [342](/filings/0001140361-25-024065.md) | [373](/filings/0001193125-24-200698.md) | [452](/filings/0001193125-24-255750.md) | [712](/filings/0001140361-25-004059.md) | [411](/filings/0001140361-26-026744.md) | [560](/filings/0001140361-25-030876.md) | [661](/filings/0001140361-25-041932.md) | [506](/filings/0001140361-26-005787.md) | [429](/filings/0001140361-26-033208.md) | [335](/filings/0001140361-26-033208.md) |
| Total liabilities | $m | [0.0](/filings/0001193125-24-044319.md) | [0.0](/filings/0001140361-25-024065.md) | [0.0](/filings/0001193125-24-200698.md) | [0.1](/filings/0001193125-24-255750.md) | [0.3](/filings/0001140361-25-004059.md) | [0.3](/filings/0001140361-26-026744.md) | [0.2](/filings/0001140361-25-030876.md) | [0.3](/filings/0001140361-25-041932.md) | [5.1](/filings/0001140361-26-005787.md) | [0.1](/filings/0001140361-26-033208.md) | [0.1](/filings/0001140361-26-033208.md) |
| Shareholders' equity | $m | [2.6](/filings/0001140361-25-024065.md) | [281](/filings/0001140361-26-026744.md) | [348](/filings/0001140361-25-041932.md) | [425](/filings/0001140361-26-005787.md) | [470](/filings/0001140361-26-005787.md) | [240](/filings/0001140361-26-033208.md) | [261](/filings/0001140361-26-033208.md) | [334](/filings/0001140361-26-005787.md) | [331](/filings/0001140361-26-005787.md) | [377](/filings/0001140361-26-033208.md) | [329](/filings/0001140361-26-033208.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2025 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(278)](/filings/0001140361-25-024065.md) | [(67.4)](/filings/0001140361-25-030876.md) | [(76.6) d](/filings/0001140361-25-041932.md) | [(45.4) d](/filings/0001140361-26-005787.md) | [230 d](/filings/0001140361-26-026744.md) | [(20.3)](/filings/0001140361-26-033208.md) | [(73.5) d](/filings/0001140361-25-041932.md) | [(2.0) d](/filings/0001140361-26-005787.md) | [(41.2) d](/filings/0001140361-26-026744.md) | [48.1](/filings/0001140361-26-033208.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 9,750,000 at 2026-08-03, from the cover of the [10-Q filed 2026-08-14](/filings/0001140361-26-033208.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.